|202.16||+2.13||+1.06%||Vol 1.09M||1Y Perf -3.95%|
|Aug 5th, 2022 15:59 DELAYED|
|- -||-0.19 -0.09%|
|Target Price||234.17||Analyst Rating||Moderate Buy 2.17|
|Potential %||15.83||Finscreener Ranking||★+ 42.79|
|Insiders Trans % 3/6/12 mo.||-/-100/-76||Value Ranking||★★+ 48.66|
|Insiders Value % 3/6/12 mo.||-/-100/-96||Growth Ranking||★★+ 49.07|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-96||Income Ranking||★★ 39.16|
|Price Range Ratio 52W %||23.01||Earnings Rating||Buy|
|Market Cap||72.66B||Earnings Date||27th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.92|
|EPS Growth Next 5 Years %||8.30|
|Avg. Weekly Volume||1.19M|
|Avg. Monthly Volume||1.22M|
|Avg. Quarterly Volume||1.48M|
CME Group Inc. (NASDAQ: CME) stock closed at 202.15 per share at the end of the most recent trading day (a 1.06% change compared to the prior day closing price) with a volume of 1.09M shares and market capitalization of 72.66B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Capital Markets industry, Financial Services sector and employs 4370 people. CME Group Inc. CEO is Terrence A. Duffy.
The one-year performance of CME Group Inc. stock is -3.95%, while year-to-date (YTD) performance is -11.51%. CME stock has a five-year performance of 60.66%. Its 52-week range is between 185.79 and 256.94, which gives CME stock a 52-week price range ratio of 23.01%
CME Group Inc. currently has a PE ratio of 26.40, a price-to-book (PB) ratio of 2.62, a price-to-sale (PS) ratio of 19.99, a price to cashflow ratio of 27.90, a PEG ratio of 2.32, a ROA of 1.53%, a ROC of 9.41% and a ROE of 10.40%. The company’s profit margin is 62.20%, its EBITDA margin is 85.40%, and its revenue ttm is $3.60 Billion , which makes it $10.03 revenue per share.
Of the last four earnings reports from CME Group Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.92 for the next earnings report. CME Group Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for CME Group Inc. is Moderate Buy (2.17), with a target price of $234.17, which is +15.83% compared to the current price. The earnings rating for CME Group Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CME Group Inc. has a dividend yield of 2.00% with a dividend per share of $4.00 and a payout ratio of 65.00%.
CME Group Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.02, ATR14 : 4.44, CCI20 : -7.31, Chaikin Money Flow : 0.08, MACD : -1.20, Money Flow Index : 51.26, ROC : -0.98, RSI : 42.53, STOCH (14,3) : 70.35, STOCH RSI : 1.00, UO : 59.97, Williams %R : -29.65), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CME Group Inc. in the last 12-months were: Bryan T. Durkin (Sold 10 000 shares of value $2 220 652 ), Charles P. Carey (Sold 1 500 shares of value $366 167 ), Daniel R. Glickman (Sold 750 shares of value $175 725 ), Derek Sammann (Sold 4 500 shares of value $1 020 757 ), Elizabeth A. Cook (Sold 1 000 shares of value $244 254 ), Hilda Harris Piell (Sold 6 447 shares of value $1 472 621 ), Howard J. Siegel (Sold 4 000 shares of value $893 000 ), Julie Holzrichter (Sold 5 000 shares of value $1 104 060 ), Kathleen M. Cronin (Sold 4 000 shares of value $908 612 ), Kendal Vroman (Sold 890 shares of value $195 800 ), Kevin D. Kometer (Sold 13 500 shares of value $3 294 503 ), Martin J. Gepsman (Sold 5 000 shares of value $1 009 785 ), Sean Tully (Sold 12 000 shares of value $2 607 205 ), Sunil K. Cutinho (Sold 9 800 shares of value $2 332 008 ), Terrence A. Duffy (Buy at a value of $353 084), Timothy S. Bitsberger (Sold 600 shares of value $132 690 )
Wed, 27 Jul 2022 12:55 GMT Analysts Are Bullish on Top Financial Stocks: CME Group (CME), Deutsche Bank AG (DB)- TipRanks. All rights reserved.
Tue, 31 May 2022 06:11 GMT CME Group (CME) Gets a Buy Rating from Jefferies- TipRanks. All rights reserved.
Thu, 28 Apr 2022 16:30 GMT Analysts Opinions Are Mixed on These Financial Stocks: CME Group (CME), Equinix (EQIX) and Markel (MKL)- TipRanks. All rights reserved.
Tue, 05 Apr 2022 12:30 GMT Analysts Are Neutral on Top Financial Stocks: CME Group (CME), Lloyds Banking (LYG)- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.